NIJHAWAN PARDEEP (Chief Executive Officer) purchased 15.7% of their position (50.57K shares) of EDESA BIOTECH, INC. on the open market
Open‑market purchase worth $99.2K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/2/2026ACC: 0001171843-26-001267
DirectorOfficer10% Owner· Chief Executive Officer
Since Jun 2019
+60.59K
Net shares
Net buyer
$99.2K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
60.59K acquired
Non-Derivative Transactions3
Common Shares
Direct
Shares
+20.57K
Price / share
$1.58
Trade value
$32.48K
% of position
3.5%
2/26/2026
595.23K→615.80K
Common Shares
Indirect
Shares
+30K
Price / share
$2.22
Trade value
$66.70K
% of position
8.8%
2/27/2026
341.70K→371.70K
Common Shares
Direct
Shares
+10.02K
Price / share
—
Trade value
—
% of position
1.6%
3/2/2026
615.80K→625.81K
Total
Net shares
+60.59K
Net value
$99.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/26/2026 | P · Purchase | +20.57K | $1.58 | $32.48K | 3.5% | 595.23K | 615.80K |
| Common Shares Indirect | 2/27/2026 | P · Purchase | +30K | $2.22 | $66.70K | 8.8% | 341.70K | 371.70K |
| Common Shares Direct | 3/2/2026 | A · Award | +10.02K | — | — | 1.6% | 615.80K | 625.81K |
| Total | +60.59K | $99.18K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Shares
IndirectShares owned53.10K
Common Shares
IndirectShares owned32.61K
Common Shares
IndirectShares owned32.01K
Total
117.73K indirect117.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 53.10K | Indirect |
| Common Shares | 32.61K | Indirect |
| Common Shares | 32.01K | Indirect |
| Total | 117.73K | 117.73K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported